To date, telemedicine has been largely focused on "first contact visits." Psoriasis presents unique challenges, including the need for long-term management. Telemedicine offers opportunities to develop novel approaches such as exploring artificial intelligence (AI) solutions and the personal management of psoriasis care. IPC convened a working group to establish a road map for how IPC can aid the development and implementation of telemedicine focused on psoriasis diagnosis and management. The telemedicine working group, chaired by Alexander Navarrini and co-chaired by Joel Gelfand, is in the process of developing a consensus statement regarding telemedicine in psoriasis management.
Chair Alexander Navarini Switzerland
Co-chair Joel Gelfand USA
Working Group Members
April Armstrong, USA Andrea Chiricozzi, Italy Vahid Diamei, Switzerland Mohamed El-Komy, Egypt Christophe Hsu, Switzerland Peter van de Kerkhof, Netherlands, IPC CMO Christy Langan, USA, IPC CEO Staff liaison: Tina Burke, USA
About IPC Our Strategic Plan IPC's plan for advancing knowledge and enhancing care for patients with psoriasis. READ MORE
IPC's plan for advancing knowledge and enhancing care for patients with psoriasis.
Latest news PsoProtect Registry Data UpdateSeptember 13, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,205 cases. July Update on PsoProtect Registry DataJuly 12, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,147 cases. Expert Opinion: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based studyJuly 07, 2021IPC Councilor, Luigi Naldi, MD, shares his expert opinion on a population-based study of COVID-19 - associated hospitalization and mortality in patients with psoriasis. Grand Rounds tutorial on IPC's psoriasis severity reclassificationJune 21, 2021The AbbVie program features IPC Board Member Bruce Strober’s Grand Rounds, a tutorial explaining the current method of measuring the severity of psoriasis, why this limits proper care and treatment for psoriasis patients, how IPC’s Disease Severity Reclassification Project solves these problems, and how clinicians can implement this new classification method. More News